Akari Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKTX and other ETFs, options, and stocks.

About AKTX

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. 

CEO
Rachelle Jacques
CEORachelle Jacques
Employees
9
Employees9
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
2004
Founded2004
Employees
9
Employees9

AKTX Key Statistics

Market cap
44.31M
Market cap44.31M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
220.10K
Average volume220.10K
High today
$0.60
High today$0.60
Low today
$0.5399
Low today$0.5399
Open price
$0.5782
Open price$0.5782
Volume
73.42K
Volume73.42K
52 Week high
$1.83
52 Week high$1.83
52 Week low
$0.5399
52 Week low$0.5399

AKTX Earnings

-$0.23
-$0.15
-$0.08
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
per share
Estimated per share
Actual
Expected Oct 7, Pre-Market
ActualExpected Oct 7, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.